AMO Development, LLC
USPTO PatentsView assignee record - 283 granted patents across 24 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).
The verdict
According to USPTO PatentsView, AMO ranks #1,468 of 49,997 tracked US assignees by granted-patent volume, with 283 patents across 24 technology areas.
- #1,468
- of 49,997 US assignees by volume
- Top 9%
- by Innovation Score (53.0/100)
- 14.0
- avg claims per patent
- +229%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R1468 · US Corporation #1,468 · 283 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MID 283 grants
- TOP-DECILE #1,468/49,997
- PHOTO-FINISH Ab Initio Technology
- CPC-FOCUS A61F · 24 areas
- INNOV-PAR 53.0/100
- CLAIMS-RICH 14.0 claims/avg
- TYPE-USCORP US Corporation
- VEL-SURGE +229% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Ab Initio Technology LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How AMO’s 53.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around AMO
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- AMO Development · this assignee
AMO Development · this assignee
53 score
- Duksan Neolux · near
Duksan Neolux · near
53 score
- Lookout · near
Lookout · near
53 score
- Shenzhen Smoore… · near
Shenzhen Smoore… · near
53 score
- Technip France · near
Technip France · near
53 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows AMO's Innovation Score is 53.0/100 (top 9% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for AMO?
Each dot is one of AMO’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). AMO’s own 14.0 claims/patent is at or below the 14.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where AMO's grants concentrate
AMO Development, LLC is a focused PatentsView assignee: 24 CPC subclasses with 90.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2020 (52 grants) versus a trough of 7 in 2018. By volume, AMO sits between Sivantos Pte. Ltd. and Atieva, Inc..
AMO's three-year grant acceleration
From 2019–2021 to 2022–2024, AMO Development, LLC moved from 101 to 117 grants (1.16x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #854. See the growth leaderboard.
Who files at AMO's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Sivantos Pte
Sivantos Pte. Ltd.
284 patents
- Toshiba Infrastru…
Toshiba Infrastructure Systems & Solutions Corporation
284 patents
- Trend Micro Incor…
Trend Micro Incorporated
284 patents
- Xiamen ECO Lighti…
Xiamen ECO Lighting Co. Ltd.
284 patents
- Ab Initio Technol…
Ab Initio Technology LLC
283 patents
- Firmenich
Firmenich SA
283 patents
- Nanjing Chervon I…
Nanjing Chervon Industry Co., Ltd.
283 patents
- AMO Development ◀
AMO Development, LLC
283 patents
- Atieva
Atieva, Inc.
282 patents
What this shows AMO holds 283 patents at rank #1,467, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near AMO
By rank, the assignees closest to #1,467 in granted patent volume.
- Sivantos Pte. Ltd. #1,463 · 284 patents
- Toshiba Infrastructure Systems & Solutions Corporation #1,464 · 284 patents
- Trend Micro Incorporated #1,465 · 284 patents
- Xiamen ECO Lighting Co. Ltd. #1,466 · 284 patents
- Ab Initio Technology LLC #1,468 · 283 patents
- Firmenich SA #1,469 · 283 patents
- Nanjing Chervon Industry Co., Ltd. #1,470 · 283 patents
- Atieva, Inc. #1,471 · 282 patents
Leaders in A61F (Filters Implantable Into Blood Vessels)
Other assignees with the most granted patents in AMO's primary technology class.
- The Procter & Gamble Company 1,426 in class
- Boston Scientific Scimed, Inc. 1,101 in class
- Edwards Lifesciences Corporation 1,101 in class
- DePuy Synthes Products, Inc. 851 in class
- Globus Medical, Inc. 752 in class
- Cook Medical Technologies LLC 700 in class
- Smith & Nephew, Inc. 541 in class
- Covidien LP 528 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for AMO, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), AMO ranks #27 of 3,082 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (53 here).
Similar claim depth
Nearest assignees by average claims per patent (14.0 here).
AMO's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
53 Top 9% higher than 91% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 10 | 3.5% |
| 2016 | 16 | 5.7% |
| 2017 | 15 | 5.3% |
| 2018 | 7 | 2.5% |
| 2019 | 14 | 4.9% |
| 2020 | 52 | 18.4% |
| 2021 | 35 | 12.4% |
| 2022 | 31 | 11.0% |
| 2023 | 40 | 14.1% |
| 2024 | 46 | 16.3% |
| 2025partial year | 17 | 6.0% |
Which technologies does AMO Development, LLC patent most?
Top 15 of 24 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
AMO Development, LLC's patent record in context - here's where to go next.
- AMO Development, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 90.1% of its portfolio - see every assignee active in that class. Explore A61F
- Ranked #1,468 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare AMO Development, LLC against Sivantos Pte. Ltd., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 53.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.